Metabolic-Associated Fatty Liver Disease (MAFLD): Nonalcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease (NAFLD/MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Dawn M. Torres; Stephen A. Harrison

doi:10.1016/B978-0-323-93637-8.00027-5

Metabolic-Associated Fatty Liver Disease (MAFLD): Nonalcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease (NAFLD/MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Dawn M. Torres
, Stephen A. Harrison

Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease in the world and one of the most common reasons for gastroenterology and hepatology consultation. This chapter will provide the reader with a concise summary of the current knowledge on the epidemiology, diagnosis, and treatment of metabolic-associated fatty liver disease, MASLD, and nonalcoholic steatohepatitis.

Original language	English
Title of host publication	Gastrointestinal and Liver Secrets
Publisher	Elsevier
Pages	223-228.e2
ISBN (Electronic)	9780323936378
ISBN (Print)	9780323936774
DOIs	https://doi.org/10.1016/B978-0-323-93637-8.00027-5
State	Published - 1 Jan 2024

Keywords

fatty liver
MAFLD
metabolic syndrome
NAFLD
NASH

Access to Document

10.1016/B978-0-323-93637-8.00027-5

Fingerprint

Dive into the research topics of 'Metabolic-Associated Fatty Liver Disease (MAFLD): Nonalcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease (NAFLD/MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)'. Together they form a unique fingerprint.

Cite this

Torres, D. M., & Harrison, S. A. (2024). Metabolic-Associated Fatty Liver Disease (MAFLD): Nonalcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease (NAFLD/MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH). In Gastrointestinal and Liver Secrets (pp. 223-228.e2). Elsevier. https://doi.org/10.1016/B978-0-323-93637-8.00027-5

@inbook{0577d63881564830955ae1da779e3a93,

title = "Metabolic-Associated Fatty Liver Disease (MAFLD): Nonalcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease (NAFLD/MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)",

abstract = "Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease in the world and one of the most common reasons for gastroenterology and hepatology consultation. This chapter will provide the reader with a concise summary of the current knowledge on the epidemiology, diagnosis, and treatment of metabolic-associated fatty liver disease, MASLD, and nonalcoholic steatohepatitis.",

keywords = "fatty liver, MAFLD, metabolic syndrome, NAFLD, NASH",

author = "Torres, \{Dawn M.\} and Harrison, \{Stephen A.\}",

year = "2024",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-93637-8.00027-5",

language = "English",

isbn = "9780323936774",

pages = "223--228.e2",

booktitle = "Gastrointestinal and Liver Secrets",

publisher = "Elsevier",

}

Metabolic-Associated Fatty Liver Disease (MAFLD): Nonalcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease (NAFLD/MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH). / Torres, Dawn M.; Harrison, Stephen A.
Gastrointestinal and Liver Secrets. Elsevier, 2024. p. 223-228.e2.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

TY - CHAP

T1 - Metabolic-Associated Fatty Liver Disease (MAFLD)

T2 - Nonalcoholic Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease (NAFLD/MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)

AU - Torres, Dawn M.

AU - Harrison, Stephen A.

PY - 2024/1/1

Y1 - 2024/1/1

N2 - Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease in the world and one of the most common reasons for gastroenterology and hepatology consultation. This chapter will provide the reader with a concise summary of the current knowledge on the epidemiology, diagnosis, and treatment of metabolic-associated fatty liver disease, MASLD, and nonalcoholic steatohepatitis.

AB - Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease in the world and one of the most common reasons for gastroenterology and hepatology consultation. This chapter will provide the reader with a concise summary of the current knowledge on the epidemiology, diagnosis, and treatment of metabolic-associated fatty liver disease, MASLD, and nonalcoholic steatohepatitis.

KW - fatty liver

KW - MAFLD

KW - metabolic syndrome

KW - NAFLD

KW - NASH

UR - https://www.scopus.com/pages/publications/105032942096

U2 - 10.1016/B978-0-323-93637-8.00027-5

DO - 10.1016/B978-0-323-93637-8.00027-5

M3 - Chapter

AN - SCOPUS:105032942096

SN - 9780323936774

SP - 223-228.e2

BT - Gastrointestinal and Liver Secrets

PB - Elsevier

ER -